Fertility and Sterility
Volume 79, Issue 1 , Pages 112-119 , January 2003

The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life

  • Gaylene Pron, Ph.D.

      Affiliations

    • Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • Center for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Gaylene Pron, Ph.D., Department of Public Health Sciences, Faculty of Medicine, University of Toronto, 100 College St., Room 513, Banting Building, Toronto, Ontario M5G 1L5, Canada (FAX: 416-971-2240).
    • ,
  • Marsha Cohen, M.D.

      Affiliations

    • Center for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • ,
  • Jennifer Soucie, M.Sc.

      Affiliations

    • Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Greg Garvin, M.D.

      Affiliations

    • Department of Radiology, St. Joseph’s Health Care, London, Ontario, Canada
    • ,
  • Leslie Vanderburgh, M.D.

      Affiliations

    • Department of Radiology, William Osler Health Center, Brampton, Ontario, Canada
    • ,
  • Stuart Bell, M.D.

      Affiliations

    • Department of Medical Imaging, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • ,
  • Ontario Uterine Fibroid Embolization Collaborative Group

Received 19 April 2002 ,Revised 16 September 2002 ,Accepted 16 September 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The Ontario Uterine Fibroid Embolization Trial was funded in part by the Boston Scientific Corporation.

PII: S0015-0282(02)04539-9

Fertility and Sterility
Volume 79, Issue 1 , Pages 112-119 , January 2003

Article Tools

* Image Usage & Resolution